Acerca de
Dr Fahad Ibnshamsah is a highly respected Consultant Medical Oncologist and Internal Medicine Specialist. He is dedicated to providing comprehensive and compassionate care to patients facing complex oncological diagnoses. With a strong commitment to advancing cancer treatment, he combines evidence-based medicine with a reassuring approach, ensuring that each patient receives a personalised treatment plan tailored to their specific needs. He also serves as an Assistant Professor of Internal Medicine, sharing his extensive clinical expertise with the next generation of medical professionals.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Fahad Ibnshamsah
Educación y formación
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncología
Carrera y nombramientos
-
2021-09–2022-08 Junior consultant
Licencias y seguros
Licencias médicas
SA — Organización Médica Colegial de España (OMC)
Certificaciones del consejo
European Board of Oncología
Seguro de responsabilidad profesional:
HDI Global · 3,000,000 EUR cobertura · No claims on file
Procedimientos realizados
| Procedimiento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 956 |
| Annual physical exam | 99395 | 266 |
| Vaccination administration | 90471 | 2,826 |
| Minor procedure (skin) | 17110 | 693 |
Servicios y precios
| Servicio | Duración | Modalidad | Precio |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 180.00 EUR |
Consulta, equipo y en práctica
Vídeos
Investigación y publicaciones
índice h: 5 · i10: 7
-
Long-term follow-up of Oncología across SA
DOI: 10.8710/euroclin.2026.0 · PMID: 37979660 · citado por 180
-
Validation of clinical scoring in Oncología
DOI: 10.5738/euroclin.2025.1 · PMID: 31282003 · citado por 102
-
Long-term follow-up of Oncología across SA
DOI: 10.9519/euroclin.2024.2 · PMID: 33838956 · citado por 16
-
Validation of clinical scoring in Oncología
DOI: 10.4283/euroclin.2023.3 · PMID: 39972240 · citado por 162
Conferencias invitadas
- Practical updates in Oncología European Annual Congress (Oncología) · Vienna · 2024 · invited
- Single-centre experience in Oncología National Society Meeting · Dammam · 2023 · oral abstract
Premios y afiliaciones
Premios
- 🏆 Top-rated Oncología — Dammam · EuroClinics Patient Choice · 2025 · regional
Membresías en sociedades
- WONCA Europe — Family Doctors — Member · Desde 2022
- national college of family doctors — Member · Desde 2022
- European Union of Medical Specialists (UEMS) — Member · Desde 2022
Artículos de este doctor
- Patient education Patient guide to Oncología
- Awareness When should you see a oncología?
Para pacientes internacionales
- Coordinador
- Patient liaison · fahad.ibnshamsah@euroclinics.example
Ubicación
1 etiquetaReseñas de pacientes
Comparta su experiencia — ayude a otros pacientes a encontrar el médico adecuado. Escribir una reseña →
Reseñas recientes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.